Diversified Chemicals

Page 1

Lonza Group AG confirms FY 2014 EBIT forecast and lowers FY 2014 revenue forecast

Friday, 31 Oct 2014 02:00am EDT

Lonza Group AG:Sees FY 2014 CORE EBIT growth of about 10 pct, despite the weaker-than-expected Water Treatment results, bringing revenue growth to under 5 pct.FY 2013 revenue 3.584 billion euros.FY 2014 revenue estimate 3.750 million euros - Thomson Reuters I/B/E/S.

GOO CHEMICAL CO LTD amends consolidated mid-year outlook for FY 2015

Friday, 31 Oct 2014 01:00am EDT

GOO CHEMICAL CO LTD:Says the company lowered the consolidated mid-year outlook for revenue to 3,723 million yen from 3,760 million yen for the fiscal year ending March 2015.Sees an increased operating profit forecast to 360 million yen from 290 million yen.Sees an increased ordinary profit forecast to 448 million yen from 350 million yen.Sees an increased net profit forecast to 266 million yen from 195 million yen.Sees an increased earnings per share to 40.18 yen from 29.41 yen.Comments the decreased costs and expenses is the main reason for the forecast.

Yuki Gosei Kogyo Co Ltd revises consolidated full-year outlook for FY 2015

Friday, 31 Oct 2014 12:00am EDT

Yuki Gosei Kogyo Co Ltd:Says the company increased the consolidated full-year outlook for revenue to 9,900 million yen from 9,600 million yen for FY ending March 2015.Operating profit forecast remains at 300 million yen.Ordinary profit forecast remains at 250 million yen.Net profit forecast increased to 270 million yen from 150 million yen.Earnings per share increased to 12.36 yen from 6.87 yen.Comments the indemnity income is the main reason for the forecast.

Evonik Industries AG reiterates FY 2014 outlook

Wednesday, 29 Oct 2014 08:00pm EDT

Evonik Industries AG:Says outlook for FY 2014 confirmed.Anticipates that FY 2014 sales will rise slightly (2013: 12.7 billion euros) and expects that adjusted EBITDA will be in lower rather than upper part of 1.8 billion euros to 2.1 billion euros range (2013: 2.0 billion euros).FY 2014 revenue estimate 12.987 billion euros - Thomson Reuters I/B/E/S.FY 2014 EBITDA estimate 1.858 billion euros - Thomson Reuters I/B/E/S.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: GlobalData
$125.00
Provider: Wright Reports
$35.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.